NCT04872699

Brief Summary

The aim of this study is to evaluate the prevalence of COVID-19 among the residents and geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), and the factors that are likely to influence this prevalence.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 22, 2021

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

May 2, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 4, 2021

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2022

Completed
Last Updated

May 4, 2021

Status Verified

May 1, 2021

Enrollment Period

1 month

First QC Date

May 2, 2021

Last Update Submit

May 2, 2021

Conditions

Keywords

elderlyCOVIDSARS-COV-2prevalencedependant carelong-term unit

Outcome Measures

Primary Outcomes (1)

  • General prevalence of COVID-19

    measures the prevalence of COVID-19 among the residents and geriatric inpatients, defined as resident and patients with positive serologic or RT-PCR test

    Through the study completion, an average of 12 months

Secondary Outcomes (7)

  • Number of asymptomatic residents/inpatients

    Through study completion, an average of 12 months

  • Number of symptomatic residents/inpatients

    Through study completion, an average of 12 months

  • Number of residents/inpatients with severe form of COVID-19 which led to an hospitalization

    Through study completion, an average of 12 months

  • Number of residents/inpatients infected with COVID-19 and hospitalized in a critical care unit

    Through study completion, an average of 12 months

  • Number of residents/inpatients infected with COVID-19 and deceased

    Through study completion, an average of 12 months

  • +2 more secondary outcomes

Interventions

Periodic testings and testings with characteristic symptoms occur

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Residents and geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), from march, 2020, to december, 2021, who are not opposed to participate in this study.

You may qualify if:

  • residents of the dependant care facility for the elderly
  • inpatients of the long-term care unit
  • from march, 2020 to december, 2021

You may not qualify if:

  • opposition to participate in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Sud Essonne

Étampes, Essonne, 91150, France

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Shidasp SIAMI, MD, PhD

    Centre Hospitalier Sud Essonne

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2021

First Posted

May 4, 2021

Study Start

April 22, 2021

Primary Completion

May 31, 2021

Study Completion

May 31, 2022

Last Updated

May 4, 2021

Record last verified: 2021-05

Locations